Skip to content

Effects of the preceding night dexmedetomidine infusion on postoperative delirium in elderly patients undergoing hip-fracture surgery

Effects of the preceding night low-dose dexmedetomidine infusion on postoperative delirium in elderly patients undergoing hip-fracture surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087107
Enrollment
Unknown
Registered
2024-07-19
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experiment Group:dexmedetomidine (0.2 ug/kg/h) was continuously infused in the night before operation to the morning of the surgical day
Control Group:accepted saline infusion with same speed

Sponsors

Shanghai Yangpu District Shidong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients planned for hip fracture surgery, including proximal femoral nail anti-rotation, cannulated screw fixation, hemiarthroplasty or total hip replacement; 2. Aged 65-90 years old; 3. American Society of Anesthesiologists (ASA) Physical Status classification I–III; 4. Underwent general anesthesia; 5. Voluntary participation in the trial and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of mental illness or disease in nerve system, including hearing and visual impairment, stroke, transient ischemic attack (TIA) and other brain diseases within 3 months; 2. Patients with a history of dementia or preoperative Minimum Mental State Examination (MMSE) Score <= 23 points, evaluated 1 day before surgery ; 3. Illiterate patients; 4. Patients with communication difficulties and unable to complete cognitive function tests; 5. Patients with a history of severe liver (Child-Pugh class C ) or kidney (requiring renal replacement therapy) disease; 6. Body mass index (BMI)?35 kg/m2, sleep apnea syndrome; 7. Long-term use of psychotropic drugs, or alcohol abuse; 8. Cardio-vascular malfunctions, including sinus bradycardia (heart rate<60 beats/min), sick sinus syndrome, Wolffian Parkinson-White syndrome, second-degree atrioventricular block, or a history of cardiovascular accidents; 9. Allergic to dexmedetomidine.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative POD;

Secondary

MeasureTime frame
Inflammatory biomarkers;

Countries

China

Contacts

Public ContactJinchao Song

Shidong Hospital of Shanghai

sjch2013@163.com+86 131 6700 0520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 11, 2026